IMA Advisory Services’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
Other funds holding IONS
VPM
VCM
IMA Advisory Services's IONS Position: Q1 2026 in Review
IMA Advisory Services increased its Ionis Pharmaceuticals (IONS) stake by 460% in Q1 2026, buying an estimated $1.81K and bringing the position to 28 shares worth $2.1K. The position accounts for ﹤0.01% of the portfolio, ranked #630.
IMA Advisory Services first reported a position in IONS in Q2 2025 and has held it in 4 quarters since. 493 funds tracked by Wall St. Rank hold IONS as of Q1 2026.
- IMA Advisory Services held 28 shares of Ionis Pharmaceuticals worth $2.1K as of Q1 2026.
- IMA Advisory Services bought 23 Ionis Pharmaceuticals shares in Q1 2026, an estimated $1.81K.
- Ionis Pharmaceuticals made up ﹤0.01% of IMA Advisory Services's portfolio in Q1 2026, its #630 holding.
- IMA Advisory Services first reported a position in Ionis Pharmaceuticals in Q2 2025 and has held it in 4 quarters since.
- 493 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2026.
Based on IMA Advisory Services's 13F filing for Q1 2026, filed 6 May 2026.